These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11190717)

  • 1. [Heart transplantation: indications and guidelines].
    Bergler-Klein J; Schlechta B; Stanek B; Hülsmann M; Berger R; Grimm M; Pacher R
    Wien Klin Wochenschr; 2000; 112(23 Pt A):14-6, 18-20. PubMed ID: 11190717
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart transplantation. Indications, results and perspectives].
    Wahlers T; Pethig K; Fieguth HG; Demertzis S; Hausen B; Mügge A; Wolpers K; Heublein B; Borst HG
    Internist (Berl); 1996 Mar; 37(3):283-8. PubMed ID: 8919945
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse outcomes from the use of older donor hearts in cardiac transplant recipients: the pros and cons of expanded donor criteria.
    Eisen HJ
    J Am Coll Cardiol; 2004 May; 43(9):1562-4. PubMed ID: 15120812
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited commentary.
    Copeland J
    Ann Thorac Surg; 2006 Jul; 82(1):33-4. PubMed ID: 16798183
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart transplantation for end-stage valvular disease: indications and results.
    Pavie A
    Curr Opin Cardiol; 2006 Mar; 21(2):100-5. PubMed ID: 16470144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited commentary.
    Reichenspurner H
    Thorac Cardiovasc Surg; 2011 Mar; 59(2):98. PubMed ID: 21500396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines from the French Society of Cardiology for including non-emergency adult patients in a waiting list for cardiac transplantation].
    Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1437-42. PubMed ID: 9539847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Update on indications and results of the surgical treatment of heart failure].
    Bocchi EA
    Arq Bras Cardiol; 1994 Dec; 63(6):523-30. PubMed ID: 7605241
    [No Abstract]   [Full Text] [Related]  

  • 11. The actual meaning of "urgency" in the practice of heart transplantation.
    Cotrufo M; De Santo LS; De Feo M; Vosa C
    Ital Heart J; 2000 Jun; 1(6):389-93. PubMed ID: 10929738
    [No Abstract]   [Full Text] [Related]  

  • 12. The University of Vienna experience in heart transplantation.
    Zuckermann A; Bohdjalian A; Deviatko E; Dunkler D; Rödler S; Ehrlich M; Wieselthaler G; Pacher R; Bunzel B; Wollenek G; Laczkovics A; Laufer G; Wolner E; Grimm M
    Clin Transpl; 2002; ():229-42. PubMed ID: 12971454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart transplantation--current status and development].
    Reichart B; Reichenspurner H
    Internist (Berl); 1990 Oct; 31(10):641-7. PubMed ID: 2283208
    [No Abstract]   [Full Text] [Related]  

  • 14. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awaiting heart transplantation--a race for survival?
    Aravot D
    Isr J Med Sci; 1996 May; 32(5):316-8. PubMed ID: 8641872
    [No Abstract]   [Full Text] [Related]  

  • 16. Should stable UNOS Status 2 patients be transplanted?
    Jimenez J; Bennett Edwards L; Higgins R; Bauerlein J; Pham S; Mallon S
    J Heart Lung Transplant; 2005 Feb; 24(2):178-83. PubMed ID: 15701434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternate waiting list strategies for heart transplantation maximize donor organ utilization.
    Chen JM; Russo MJ; Hammond KM; Mancini DM; Kherani AR; Fal JM; Mazzeo PA; Pinney SP; Edwards NM; Naka Y
    Ann Thorac Surg; 2005 Jul; 80(1):224-8. PubMed ID: 15975371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients.
    Roussel JC; Sénage T; Baron O; Périgaud C; Habash O; Rigal JC; Treilhaud M; Trochu JN; Despins P; Duveau D
    Ann Thorac Surg; 2009 Jan; 87(1):124-9; discussion 130. PubMed ID: 19101284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of heart transplantation in the therapy of heart failure].
    Borst HG; Heublein B; Haverich A
    Verh Dtsch Ges Inn Med; 1991; 97():187-94. PubMed ID: 1808884
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac resynchronization therapy: long-term alternative to cardiac transplantation?
    Hansky B; Vogt J; Zittermann A; Güldner H; Heintze J; Schulz U; Horstkotte D; Tenderich G; Körfer R
    Ann Thorac Surg; 2009 Feb; 87(2):432-8. PubMed ID: 19161754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.